As COVID-19 cases continue to skyrocket in the U.S., the FDA authorized a third dose of the Pfizer-BioNTech COVID-19 vaccine for kids aged 12 to 15, and for 5 to 11-year-olds who are immunocompromised
and BioNTech COVID-19 vaccine for children ages 12 to 15, and narrowed the interval for booster shot eligibility to five months from six.
The U.S. government has been urging vaccinated Americans to get boosters and for the unvaccinated, who are at much higher risk of severe COVID-19 and death, to be inoculated. In making its decision, the FDA said it reviewed real-world evidence from Israel, including safety data from more than 6,300 individuals aged 12 through 15 years who received a booster dose of the Pfizer-BioNTech vaccine at least 5 months following completion of the primary two-dose vaccination series.
The FDA will weigh boosters for 5- to 11 year-olds after more children receive two doses, Marks said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA authorizes Pfizer Covid-19 vaccine boosters for 12- to 15-year-oldsThe US kicked off 2022 amid a massive Covid-19 case spike — driven by the highly contagious Omicron variant — that some experts warn will be different than any other time in the pandemic.
Lire la suite »
FDA expands Pfizer COVID-19 boosters for 12- to 15-year-olds as omicron surgesThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the FDA allowing extra Pfizer shots for children as young as 12.
Lire la suite »
FDA expands Pfizer COVID-19 vaccine booster for ages 12 to 15The FDA expanded Pfizer’s COVID-19 vaccine booster for kids as young as 12. Final approval from the CDC is still needed.
Lire la suite »
COVID live updates: More than 100,000 Americans hospitalized with COVID-19LATEST: New York City Mayor Eric Adams insisted that schools will stay open for in-person leaning despite the rapidly rising number of COVID cases.
Lire la suite »
Belgium agrees to buy 10,000 courses each of Pfizer, Merck COVID-19 pillsBelgium has agreed to buy 10,000 courses each of the COVID-19 antiviral oral treatments developed by Pfizer and Merck & CO , a spokesman for the health ministry told Reuters in an emailed statement on Monday.
Lire la suite »